Taking the 'GLP-1 receptor agonist' class of anti-obesity drugs is related with lower rates of post-surgery complications in people with diabetes, according to a study. Patients taking the anti ...

Obesity is a factor contributing to the occurrence of hypertension and a risk factor for adverse outcomes in populations with hypertension. The changes in the prevalence of obesity in populations with ...

GLP-1 receptor agonist, or GLP-1 RA, drugs help treat diabetes by weight loss, improving blood glucose levels and increasing insulin sensitivity, low levels of which are a risk factor for diabetes.

Nov. 26, 2024 — Tirzepatide, a new injectable weight-loss drug, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with ...

Taking the ‘GLP-1 receptor agonist’ class of anti-obesity drugs is related with lower rates of post-surgery complications in people with diabetes, according to a study. GLP-1 receptor agonist, or ...

New Delhi, Jan 7 (PTI) Taking the 'GLP-1 receptor agonist' class of anti-obesity drugs is related with lower rates of post-surgery complications in people with diabetes, according to a study. GLP-1 ...

The top U.S. health official is calling for all alcoholic beverages to carry a warning label about cancer risk.

Getting older comes with risks like dementia, vision and hearing loss, and other physical ailments. Adopting certain behaviors can help reduce those risks.

recognizing our 40-year partnership with the American Heart Association in developing clinical guidelines, and so much more. Over the last year, the pages of Cardiology have also featured inside looks ...